CO4990933A1 - Derivados de indazol triciclicos, su preparacion y su apli- cacion en terapeutica - Google Patents

Derivados de indazol triciclicos, su preparacion y su apli- cacion en terapeutica

Info

Publication number
CO4990933A1
CO4990933A1 CO98060914A CO98060914A CO4990933A1 CO 4990933 A1 CO4990933 A1 CO 4990933A1 CO 98060914 A CO98060914 A CO 98060914A CO 98060914 A CO98060914 A CO 98060914A CO 4990933 A1 CO4990933 A1 CO 4990933A1
Authority
CO
Colombia
Prior art keywords
group
indazol
therapeutics
preparation
application
Prior art date
Application number
CO98060914A
Other languages
English (en)
Inventor
Even Luc
Claudie Gautier
Michel Aletru
Philippe Bovy
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of CO4990933A1 publication Critical patent/CO4990933A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compuesto de fórmula (I)en la cual: R1 representa un átomo de hidrógeno, un halógeno, un grupo C1-4 alcoxilo, metilo, hidroxi o amino, R2 y R3 , idénticos o diferentes, representan un átomo de hidrógeno, un grupo alquilo de 1 a 4 átomos de carbono, un fenilo o un bencilo, X representa un átomo de oxígeno, un grupo -NH- o -N(C1-4 alquilo)-, y A es un grupo de fórmula B o C en las cuales:Y representa un átomo de nitrógeno o un grupo metileno, R4 representa un átomo de hidrógeno, un grupo alquilo de 1 a 4 átomos de carbono, un bencilo, n es igual a O o 1, y m es igual a O o 1, en forma de enantiómero, de diastereoisómero, incluida la mezcla racémica así como sus sales de adición con ácidos farmacéuticamente aceptables.
CO98060914A 1997-10-21 1998-10-20 Derivados de indazol triciclicos, su preparacion y su apli- cacion en terapeutica CO4990933A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9713149A FR2769915B1 (fr) 1997-10-21 1997-10-21 Derives d'indazole tricycliques, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
CO4990933A1 true CO4990933A1 (es) 2000-12-26

Family

ID=9512452

Family Applications (1)

Application Number Title Priority Date Filing Date
CO98060914A CO4990933A1 (es) 1997-10-21 1998-10-20 Derivados de indazol triciclicos, su preparacion y su apli- cacion en terapeutica

Country Status (9)

Country Link
EP (1) EP1025109A1 (es)
JP (1) JP2001520231A (es)
AR (1) AR017366A1 (es)
AU (1) AU9633098A (es)
CO (1) CO4990933A1 (es)
FR (1) FR2769915B1 (es)
TW (1) TW407160B (es)
WO (1) WO1999020633A1 (es)
ZA (1) ZA989556B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US6558708B1 (en) * 1995-05-17 2003-05-06 Cedars-Sinai Medical Center Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
FR2792318B1 (fr) * 1999-04-16 2001-06-15 Synthelabo Derives d'indazole, leur preparation et leur application en therapeutique
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
EA007429B1 (ru) 2001-10-02 2006-10-27 Фармация Энд Апджон Компани Азабициклические замещённые конденсированные гетероарильные соединения
CA2466344A1 (en) 2001-11-09 2003-05-22 Pharmacia & Upjohn Company Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands
WO2003070731A2 (en) 2002-02-19 2003-08-28 Pharmacia & Upjohn Company Azabicyclic compounds for the treatment of disease
AU2003219690A1 (en) 2002-02-19 2003-09-09 Pharmacia And Upjohn Company Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
TW200533348A (en) 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US7728006B2 (en) 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
ES2327142T3 (es) 2004-11-05 2009-10-26 Theravance, Inc. Compuestos de quinolinona-carboxamida.
JP5086091B2 (ja) 2004-11-05 2012-11-28 セラヴァンス， インコーポレーテッド ５−ｈｔ４受容体アゴニスト化合物
MX2007007328A (es) * 2004-12-22 2007-07-25 Memory Pharm Corp Ligandos del receptor alfa-7 nicotinico y preparacion y sus usos.
MX2007007818A (es) 2004-12-22 2007-09-11 Theravance Inc Compuestos de indazol-carboxamida.
BRPI0608392A2 (pt) 2005-03-02 2009-12-29 Theravance Inc compostos de quinolinona como agonistas do receptor 5-ht4
JP4375749B2 (ja) 2005-11-22 2009-12-02 本田技研工業株式会社 車両の樹脂製ガーニッシュ構造
WO2007120599A2 (en) 2006-04-12 2007-10-25 Wyeth Dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0350130A3 (en) * 1988-07-07 1991-07-10 Duphar International Research B.V New substituted 1,7-annelated 1h-indazoles
FR2753196B1 (fr) * 1996-09-12 1998-10-23 Synthelabo Derives d'indazole tricyclique, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
AR017366A1 (es) 2001-09-05
EP1025109A1 (en) 2000-08-09
ZA989556B (en) 1999-04-20
TW407160B (en) 2000-10-01
FR2769915B1 (fr) 2000-10-13
AU9633098A (en) 1999-05-10
JP2001520231A (ja) 2001-10-30
FR2769915A1 (fr) 1999-04-23
WO1999020633A1 (fr) 1999-04-29

Similar Documents

Publication Publication Date Title
CO4990933A1 (es) Derivados de indazol triciclicos, su preparacion y su apli- cacion en terapeutica
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
DK0915866T3 (da) Forbedret fremgangsmåde til syntese af beskyttende estere af (S)-3,4-dihydroxysmørsyre
HUP0201385A2 (hu) Eljárás a 4"-szubsztituált 9-dezoxo-9a-aza-9a-homoeritromicin-A-származékok előállítására
EA200000731A1 (ru) Альфа-аминоамидные производные, полезные в качестве анальгетических агентов
TNSN04208A1 (fr) Derives de n-[phenyl(piperidin-2-yl)methyl] benzamide, leur preparation et leur application en therapeutique
HUP0002830A2 (hu) Indol- és 2,3-dihidroindol-származékok, előállításuk és gyógyászati alkalmazásuk
EA200100994A1 (ru) 1-АМИНОТРИАЗОЛО[4,3-а]ХИНАЗОЛИН-5-ОНЫ И/ИЛИ -5-ТИОНЫ, ИНГИБИРУЮЩИЕ ФОСФОДИЭСТЕРАЗУ-IV
CO4990965A1 (es) Derivados de 1,3,8-triazaspiro(4,5)decan-4-ona to que los contiene y un proceso para la preparacion de es- tos derivados
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
HUP0301706A2 (hu) Comt gátló hatással rendelkezż kumarinszármazékok, ilyen vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
AR035451A1 (es) Derivados de beta-carbolina, su uso para la fabricacion de un medicamento para el tratamiento de la depresion, ansiedad y desordenes bipolares, una composicion farmaceutica y una combinacion.
HUP0303361A2 (hu) Helyettesített 1-amino-bután-3-ol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
EA200101230A1 (ru) Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции
HUP0003861A2 (hu) Kinolin-4-il-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
DE60202969D1 (de) Substituierte alkylaminopyridazinonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE60103752D1 (de) Verfahren zur herstellung von pyrazolopyridinderivaten
AR020294A1 (es) COMPUESTOS DERIVADOS DE 1-TRIFLUOROMETIL-4-HIDROXI-7-PIPERIDINIL-AMINOMETILCROMANO, COMPOSICION FARMACEUTICA Y USO EN LA PREPARACIoN DE MEDICAMENTOS.
UY26568A1 (es) Nuevos derivados de amidas heterocíclicas
FR2795727B1 (fr) Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique
DE68912055T2 (de) Aryloxy-, Arylthio-, Heteroaryloxy-, Heteroarylthio-Alkenylen-Derivate von Aminen.
AR009556A1 (es) Compuestos derivados de indazol triciclico, procedimiento de preparacion del mismo; medicamento y composicion farmaceutica que lo contienen
EA200000598A1 (ru) Новые ингибиторы металлопротеазы, способ их получения и содержащие их фармацевтические композиции
DK0971899T3 (da) Hexahydroindenopyridinforbindelser med antispermatogen virkning
HUP0201255A2 (hu) Új pirimidin-4-on-származékok, eljárás előállításukra, és az ezeket tartalmazó gyógyászati készítmények